{"id":"W1481320494","doi":"10.1002/ppul.23146","title":"Novel outcome measures for clinical trials in cystic fibrosis","year":2014,"lang":"en","type":"review","venue":"Pediatric Pulmonology","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; Novartis Pharma; Deutsche Forschungsgemeinschaft; Erasmus Medisch Centrum; Insmed; Bundesministerium für Bildung und Forschung; National Heart, Lung, and Blood Institute; Gilead Sciences; National Institutes of Health; Vertex Pharmaceuticals; PTC Therapeutics; Eli Lilly and Company","keywords":"Medicine; Cystic fibrosis; Clinical trial; Intensive care medicine; Disease; Clinical endpoint; Bioinformatics; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01847112,0.0007279257,0.01178435,0.001505122,0.00006473466,0.00003793038,0.0006485081,0.001495362,0.00008953678],"category_scores_gemma":[0.1477343,0.0005359352,0.002582892,0.0008736458,0.0002045712,0.00006247351,0.0002286685,0.001542833,0.0002798247],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003415663,"about_ca_system_score_gemma":0.001272193,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003840967,"about_ca_topic_score_gemma":0.00002814372,"domain_scores_codex":[0.9881463,0.002595668,0.006278726,0.001295331,0.0005284048,0.001155592],"domain_scores_gemma":[0.956637,0.03980089,0.001853983,0.001017615,0.0002331486,0.0004573616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004391421,0.0003978895,0.005112409,0.03595471,0.0001990165,0.0000311652,0.000004118605,7.196224e-7,0.000001121227,0.00008687643,0.004385967,0.9533868],"study_design_scores_gemma":[0.002622266,0.000945346,0.0008093419,0.001351486,0.003708964,0.0001661718,0.00000302653,0.00003305862,1.3865e-7,0.000187054,0.9897363,0.0004368195],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001835485,0.9840568,0.008671017,0.0002558906,0.001482595,0.004959095,0.0003478566,0.00009669967,0.0001117181],"genre_scores_gemma":[0.00002664719,0.9772297,0.01462316,0.00008638869,0.004526286,0.002591749,0.0003223308,0.0001365495,0.0004571597],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9853504,"threshold_uncertainty_score":0.9998009,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3397917721564899,"score_gpt":0.5405344356487661,"score_spread":0.2007426634922762,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}